VAERS Datenanalyse und Statistik
Zurueck zur Suche

Reporte zur Charge N034411

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MT 1 SC 1

VAERS 1731790

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge N034411

mild
Staat
MT
Alter
1,7
Geschlecht
M
Eingang
24.09.2021
Impfdatum
12.02.2019
Beginn
24.02.2019
Tage bis Beginn
12,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Pyrexia Rash Vaccination complication

Symptomtext

Patient presented to the Emergency Department for evaluation, and he was triaged to room. I reviewed the nursing notes, and he was evaluated by me. Patient presents to the ED with a mild fever followed by a rash after having his MMR vaccine 12 days ago. His exam is with a mild rash here in the ED but is otherwise reassuring. He is non-toxic appearing and is quite active here in the ED. Interestingly, the timing of his rash and fever coincides perfectly with a reaction to the vaccine, particularly the measles component. He has not had any contact with known infected persons nor has he been in any endemic areas. I don't feel that he has a wild type infection at this time. I feel that continued outpatient management is indicated however we did provide the parents with extensive return precautions. We discussed these precautions and answered the questions that they had. He will follow up with his PCP and will return to the ED for any persistent, worsening, or worrisome symptoms. I wish him the best. Final Diagnosis: 1. Reaction to MMR vaccination; 2. Rash; 3. Fever

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Amoxicillin
Vorherige Impfungen
-

VAERS 2721133

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge N034411

gering
Staat
SC
Alter
1,0
Geschlecht
F
Eingang
05.12.2023
Impfdatum
05.12.2019
Beginn
05.12.2019
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

No adverse event; Expired vaccine used; This spontaneous report was received from a health professional referring to a 12-month-old female patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication. On 05-DEC-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot number N034411 and expiration date of 04-DEC-2019 (expired product administered), at a dose of 0.5 milliliter/once for prophylaxis (route of administration and anatomical location were not reported). The reporter stated she noticed a missing expiration date in the patient's record while reviewing documentation for a immunization chart audit. The reporter stated the dose administered to the patient on 05-DEC-2019 was given at another provider's office and she was unable to provide the necessary information regarding prior excursion history to perform a stability evaluation. This agent was unable to perform a stability evaluation of unsupported or supported due to insufficient data. Additionally, the reporter was unable to provide the lot number and expiration date for the diluent used to administer the vaccine due to lack of documentation. There was no report of any issues or side effects from the patient after receiving the expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). No additional adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-